Korea United Pharm Inc.

KOSE:A033270 Stock Report

Market Cap: ₩279.5b

Korea United Pharm Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Duk-Young Kang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership29.0%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Duk-Young Kang (77 yo)

no data

Tenure

Mr. Deok-Yeong Kang serves as the Chief Executive Officer of Korea United Pharm Inc. Mr. Kang served as the Chief Executive Officer of Yeonhap Medical. He served as a Director of Korea United Pharm Inc. Mr...